Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Clinical & Experimental Metastasis
Published in: Clinical & Experimental Metastasis 6/2012

01-08-2012 | Dedication

Kurt Hellmann D.M., D.Phil. Oxon. A happy 90th birthday!

Authors: Suzanne A. Eccles, Rudolf K. Steiner

Published in: Clinical & Experimental Metastasis | Issue 6/2012

Login to get access

Excerpt

https://static-content.springer.com/image/art%3A10.1007%2Fs10585-012-9490-4/MediaObjects/10585_2012_9490_Figa_HTML.jpg May 12th marked the 90th birthday of the medical pharmacologist Kurt Hellmann—one of the most eminent pioneers in metastasis research—whose foresight in science and medicine is unparalleled. …
Metadata
Title
Kurt Hellmann D.M., D.Phil. Oxon. A happy 90th birthday!
Authors
Suzanne A. Eccles
Rudolf K. Steiner
Publication date
01-08-2012
Publisher
Springer Netherlands
Published in
Clinical & Experimental Metastasis / Issue 6/2012
Print ISSN: 0262-0898
Electronic ISSN: 1573-7276
DOI
https://doi.org/10.1007/s10585-012-9490-4

Other articles of this Issue 6/2012

Clinical & Experimental Metastasis 6/2012 Go to the issue

Research Paper

Phosphorylation of signal transducer and activator of transcription 3 (STAT3) correlates with Her-2 status, carbonic anhydrase 9 expression and prognosis in esophageal cancer

Research Paper

In vivo imaging of colorectal cancer growth and metastasis by targeting MACC1 with shRNA in xenografted mice

Research Paper

Ezrin and BCAR1/p130Cas mediate breast cancer growth as 3-D spheroids

Research Paper

RAF-kinase inhibitor protein (RKIP) downregulation in esophageal cancer and its metastases

Research Paper

Targeting monocyte chemotactic protein-1 synthesis with bindarit induces tumor regression in prostate and breast cancer animal models

Research Paper

CCL27–CCR10 and CXCL12–CXCR4 chemokine ligand-receptor mRNA expression ratio: new predictive factors of tumor progression in cutaneous malignant melanoma
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits